Blue Jet Healthcare Limited (BLUEJET.NS)
INR 584.5
(1.93%)
INR 584.5
(1.93%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -830.93 Million INR | -37.35% |
| 2022 | -604.98 Million INR | -6.97% |
| 2021 | -565.56 Million INR | -605.89% |
| 2020 | -80.12 Million INR | -111.87% |
| 2019 | 674.93 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -287.52 Million INR | -108.98% |
| 2024 Q1 | 3.2 Billion INR | 485.34% |
| 2023 FY | -830.93 Million INR | -37.35% |
| 2023 Q1 | -626.36 Million INR | -1.03% |
| 2023 Q3 | 2.82 Billion INR | 505.95% |
| 2023 Q2 | -697.03 Million INR | -11.28% |
| 2023 Q4 | -830.93 Million INR | -129.37% |
| 2022 Q1 | -857.13 Million INR | 0.0% |
| 2022 Q4 | -619.98 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Biocon Limited | 140.18 Billion INR | 100.593% |
| Concord Biotech Limited | -54.04 Million INR | -1437.478% |
| Dishman Carbogen Amcis Limited | 18.99 Billion INR | 104.375% |
| Jubilant Ingrevia Limited | 6.6 Billion INR | 112.577% |
| Lyka Labs Limited | 527.01 Million INR | 257.668% |
| Panacea Biotec Limited | -1.18 Billion INR | 29.873% |
| Piramal Pharma Limited | 42.27 Billion INR | 101.965% |
| SMS Lifesciences India Limited | 992.31 Million INR | 183.737% |
| Supriya Lifescience Limited | -694.68 Million INR | -19.613% |
| Syngene International Limited | -83 Million INR | -901.12% |
| TAKE Solutions Limited | 361.37 Million INR | 329.939% |
| Zota Health Care Limited | 942.79 Million INR | 188.134% |